Natera, Inc.
General ticker "NTRA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $21.7B (TTM average)
Natera, Inc. follows the US Stock Market performance with the rate: 59.4%.
Estimated limits based on current volatility of 1.2%: low 236.38$, high 242.22$
Factors to consider:
- Total employees count: 4434 (+34.6%) as of 2024
- US accounted for 97.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key products, Operational and conduct risks, Third-party risks, Senior management dependency, Economic downturns and volatility
- Current price 30.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [78.73$, 185.48$]
- 2025-12-31 to 2026-12-31 estimated range: [51.82$, 130.11$]
Financial Metrics affecting the NTRA estimates:
- Negative: with PPE of -104.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 0.05 <= 0.79
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 71.98 > 63.39
- Positive: Investing cash flow per share per price, % of 0.69 > -0.66
- Negative: negative Net income
Short-term NTRA quotes
Long-term NTRA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $820.22MM | $1,082.57MM | $1,696.91MM |
| Operating Expenses | $1,361.26MM | $1,528.82MM | $1,919.20MM |
| Operating Income | $-541.04MM | $-446.25MM | $-222.29MM |
| Non-Operating Income | $-5.78MM | $11.71MM | $32.56MM |
| Interest Expense | $9.32MM | $12.64MM | $10.69MM |
| R&D Expense | $316.42MM | $320.68MM | $404.14MM |
| Income(Loss) | $-546.82MM | $-434.53MM | $-189.73MM |
| Taxes | $0.98MM | $0.27MM | $0.69MM |
| Profit(Loss)* | $-547.80MM | $-434.80MM | $-190.43MM |
| Stockholders Equity | $705.74MM | $765.33MM | $1,195.42MM |
| Inventory | $35.41MM | $40.76MM | $44.74MM |
| Assets | $1,394.47MM | $1,441.70MM | $1,660.73MM |
| Operating Cash Flow | $-431.50MM | $-246.96MM | $135.66MM |
| Capital expenditure | $47.70MM | $39.20MM | $66.42MM |
| Investing Cash Flow | $330.34MM | $168.50MM | $137.62MM |
| Financing Cash Flow | $482.64MM | $254.46MM | $30.20MM |
| Earnings Per Share** | $-5.57 | $-3.78 | $-1.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.